{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:50:23Z","timestamp":1770418223010,"version":"3.49.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014452","name":"College of Medicine, University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dysregulation of complement system is thought to be a major player in development of multi-organ damage and adverse outcomes in patients with coronavirus disease 2019 (COVID-19). This study aimed to examine associations between complement system activity and development of severe acute kidney injury (AKI) among hospitalized COVID-19 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>In this multicenter, international study, complement as well as inflammatory and thrombotic parameters were analyzed in COVID-19 patients requiring hospitalization at one US and two Hungarian centers. The primary endpoint was development of severe AKI defined by KDIGO stage 2+3 criteria, while the secondary endpoint was need for renal replacement therapy (RRT). Complement markers with significant associations with endpoints were then correlated with a panel of inflammatory and thrombotic biomarkers and assessed for independent association with outcome measures using logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 131 hospitalized COVID-19 patients (median age 66 [IQR, 54\u201375] years; 54.2% males) were enrolled, 33 from the US, and 98 from Hungary. There was a greater prevalence of complement over-activation and consumption in those who developed severe AKI and need for RRT during hospitalization. C3a\/C3 ratio was increased in groups developing severe AKI (3.29 vs. 1.71; <jats:italic>p<\/jats:italic> &amp;lt; 0.001) and requiring RRT (3.42 vs. 1.79; <jats:italic>p<\/jats:italic> &amp;lt; 0.001) in each cohort. Decrease in alternative and classical pathway activity, and consumption of C4 below reference range, as well as elevation of complement activation marker C3a above the normal was more common in patients progressing to severe AKI. In the Hungarian cohort, each standard deviation increase in C3a (<jats:italic>SD<\/jats:italic> = 210.1) was independently associated with 89.7% increased odds of developing severe AKI (95% CI, 7.6\u2013234.5%). Complement was extensively correlated with an array of inflammatory biomarkers and a prothrombotic state.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Consumption and dysregulation of complement system is associated with development of severe AKI in COVID-19 patients and could represent a promising therapeutic target for reducing thrombotic microangiopathy in SARS-CoV-2 infection.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.796109","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T07:13:52Z","timestamp":1651216432000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study"],"prefix":"10.3389","volume":"9","author":[{"given":"Brandon M.","family":"Henry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Sinkovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Szergyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena Santos","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin L.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Pode-Shakked","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie W.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Iv\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"G\u00e1l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marienn","family":"R\u00e9ti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Gopcsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Rem\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Be\u00e1ta","family":"Szathm\u00e1ry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Botond","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Szl\u00e1vik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilona","family":"Bobek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zita Z.","family":"Proh\u00e1szka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"F\u00f6rh\u00e9cz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorottya","family":"Csuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Hurler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Kajd\u00e1csi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Cervenak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanka","family":"Mez\u0151","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Kiszel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"Masszi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"V\u00e1lyi-Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1515\/cclm-2020-1284","article-title":"The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro-inflammatory cytokine response in coronavirus disease 2019 (COVID-19)","volume":"59","author":"Henry","year":"2021","journal-title":"Clin Chem Lab Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cca.2020.04.027","article-title":"Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis","volume":"507","author":"Henry","year":"2020","journal-title":"Clin Chim Acta."},{"key":"B3","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res."},{"key":"B5","doi-asserted-by":"crossref","unstructured":"GaoT\n            HuM\n            ZhangX\n            LiH\n            ZhuL\n            LiuH\n          Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. medRxiv [preprint]2020","DOI":"10.1101\/2020.03.29.20041962"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1002\/jmv.27077","article-title":"Complement levels at admission as a reflection of Coronavirus Disease 2019 (COVID-19) severity state","volume":"93","author":"Henry","year":"2021","journal-title":"J Med Virol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"663187","DOI":"10.3389\/fimmu.2021.663187","article-title":"Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection","volume":"12","author":"Sinkovits","year":"2021","journal-title":"Front Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ccc.2019.11.004","article-title":"Typical and atypical hemolytic uremic syndrome in the critically ill","volume":"36","author":"Manrique-Caballero","year":"2020","journal-title":"Crit Care Clin."},{"key":"B11","doi-asserted-by":"publisher","first-page":"J276","DOI":"10.1016\/j.jaut.2009.11.014","article-title":"The complement system in systemic autoimmune disease","volume":"34","author":"Chen","year":"2010","journal-title":"J Autoimmun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrrheum.2010.158","article-title":"ANCA-associated vasculitides\u2013advances in pathogenesis and treatment","volume":"6","author":"Chen","year":"2010","journal-title":"Nat Rev Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a target in COVID-19?","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","article-title":"Endothelium structure and function in kidney health and disease","volume":"15","author":"Jourde-Chiche","year":"2019","journal-title":"Nat Rev Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ijlh.13415","article-title":"ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy","volume":"43","author":"Henry","year":"2020","journal-title":"Int J Lab Hematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: a defence system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood-2013-04-495853","article-title":"The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status","volume":"123","author":"Rayes","year":"2014","journal-title":"Blood."},{"key":"B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.xkme.2020.11.008","article-title":"The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis","volume":"3","author":"Silver","year":"2021","journal-title":"Kidney Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3389\/fmed.2020.00436","article-title":"Identify the risk factors of COVID-19-related acute kidney injury: a single-center, retrospective cohort study","volume":"7","author":"Wang","year":"2020","journal-title":"Front Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/ckj\/sfaa099","article-title":"Characterisation of acute kidney injury in critically ill patients with severe Coronavirus Disease-2019 (COVID-19)","volume":"13","author":"Rubin","year":"2020","journal-title":"Clin Kidney J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/kisup.2012.4","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int"},{"key":"B22","first-page":"205","article-title":"A micromodification of the CH50 test for the classical pathway of complement","volume":"14","author":"Fetterhoff","year":"1984","journal-title":"J Clin Lab Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","article-title":"Complement activation in thrombotic thrombocytopenic purpura: complement activation in TTP","volume":"10","author":"R\u00e9ti","year":"2012","journal-title":"J Thromb Haemost."},{"key":"B24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0022-1759(88)90160-3","article-title":"An ELISA technique for the measurement of C1q in cerebrospinal fluid","volume":"114","author":"Delamarche","year":"1988","journal-title":"J Immunol Methods."},{"key":"B25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/01621459.1983.10477989","article-title":"A network algorithm for performing Fisher's Exact Test in r \u00d7 c Contingency Tables","volume":"78","author":"Mehta","year":"1983","journal-title":"J Am Stat Assoc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"i30","DOI":"10.1093\/ckj\/sfab003","article-title":"Pathology of COVID-19-associated acute kidney injury","volume":"14","author":"Sharma","year":"2021","journal-title":"Clin Kidney J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.118.034600","article-title":"Functional relevance of the Anaphylatoxin Receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis","volume":"138","author":"Sauter","year":"2018","journal-title":"Circulation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2021.12.040","article-title":"Complement activation induces excessive T cell cytotoxicity in severe COVID-19","volume":"185","author":"Georg","year":"2022","journal-title":"Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1681\/ASN.2020050615","article-title":"AKI in hospitalized patients with COVID-19","volume":"32","author":"Chan","year":"2021","journal-title":"J Am Soc Nephrol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1681\/ASN.2020060897","article-title":"AKI treated with renal replacement therapy in critically ill patients with COVID-19","volume":"32","author":"Gupta","year":"2021","journal-title":"J Am Soc Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.26355\/eurrev_202004_20875","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin Immunol Orlando Fla."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.3390\/v13122429","article-title":"Soliris to stop immune-mediated death in COVID-19 (SOLID-C19)\u2014A compassionate-use study of terminal complement blockade in critically ill patients with COVID-19-related adult respiratory distress syndrome","volume":"13","author":"Pitts","year":"2021","journal-title":"Viruses."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0261113","DOI":"10.1371\/journal.pone.0261113","article-title":"Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: retrospective cohort study","volume":"16","author":"Ruggenenti","year":"2021","journal-title":"PLoS ONE."},{"key":"B36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40620-021-01125-8","article-title":"COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy","volume":"35","author":"Gill","year":"2022","journal-title":"J Nephrol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40620-021-01057-3","article-title":"COVID-19 in a kidney transplant recipient treated with eculizumab for atypical hemolytic uremic syndrome: a case report","volume":"34","author":"Cognard","year":"2021","journal-title":"J Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"108598","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy","volume":"220","author":"Mastellos","year":"2020","journal-title":"Clin Immunol Orlando Fla."},{"key":"B39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/jth.12826","article-title":"Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity","volume":"13","author":"Zafrani","year":"2015","journal-title":"J Thromb Haemost."},{"key":"B40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell Mol Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","article-title":"NET impact on deep vein thrombosis","volume":"32","author":"Fuchs","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","article-title":"Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies","volume":"120","author":"Fuchs","year":"2012","journal-title":"Blood."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","article-title":"Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state","volume":"33","author":"Borissoff","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/cei.12654","article-title":"Neutrophil extracellular traps can activate alternative complement pathways","volume":"181","author":"Wang","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1111\/bjh.16916","article-title":"Terminal complement inhibition dampens the inflammation during COVID-19","volume":"190","author":"Kulasekararaj","year":"2020","journal-title":"Br J Haematol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e2020008","DOI":"10.23750\/abm.v91i3.10217","article-title":"Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis","volume":"91","author":"Henry","year":"2020","journal-title":"Acta Bio Medica Atenei Parm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"108726","DOI":"10.1016\/j.clim.2021.108726","article-title":"Genetic justification of severe COVID-19 using a rigorous algorithm","volume":"226","author":"Gavriilaki","year":"2021","journal-title":"Clin Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"102595","DOI":"10.1016\/j.jaut.2021.102595","article-title":"Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19","volume":"117","author":"Valenti","year":"2021","journal-title":"J Autoimmun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.molimm.2021.03.021","article-title":"SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection","volume":"135","author":"Tsiftsoglou","year":"2021","journal-title":"Mol Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1515\/cclm-2020-1121","article-title":"Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin Chem Lab Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.796109\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T07:13:59Z","timestamp":1651216439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.796109\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":52,"alternative-id":["10.3389\/fmed.2022.796109"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.796109","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"article-number":"796109"}}